Write in a clean editor, then format for HIV Medicine in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
HIV Medicine is a peer-reviewed journal published by Wiley, covering HIV/AIDS Research and Interventions, HIV-related health complications and treatments, HIV/AIDS drug development and treatment.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." HIV Medicine 12 (3): 45–58.
Formats any DOI in HIV Medicine style. No sign-up. |
| Publishes research in | HIV/AIDS Research and Interventions HIV-related health complications and treatments HIV/AIDS drug development and treatment HIV Research and Treatment HIV, Drug Use, Sexual Risk |
| ISSN | 1464-2662 |
| Citation impact (2-yr) | 1.73 |
| h-index | 101 |
| i10-index | 1,457 |
| Total citations | 64,115 |
| Article processing charge | $3,760 |
| Top institutions publishing here | University College London |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Table of contents 1.0 Introduction 2.0 Methodology 2.1 Basing recommendations on evidence 2.2 Implications for research 2.3 Use of surrogate marker data 2.4 Issues concerning design and analysis of clinical trials 2.4.1 Trial designs 2.4.2 Viral load outcome measures 2.4.3 Noninferiority 2.4.4 Cross-study comparisons and presentation of data 2.5 Adverse event reporting 3.0 When to…
OBJECTIVES: Across Europe, almost a third of individuals infected with HIV do not enter health care until late in the course of their infection. Surveillance to identify the extent to which late presentation occurs remains inadequate across Europe and is further complicated by the lack of a common clinical definition of late presentation. The objective…
Objectives Life expectancy is an important indicator informing decision making in policies relating to HIV ‐infected people. Studies estimating life expectancy after starting combination antiretroviral therapy ( cART ) have noted differences between income regions. The objective of our study was to perform a meta‐analysis to assess life expectancy of HIV ‐positive people after starting…
BACKGROUND: To determine if infectious disease events in HIV-infected patients treated with highly active antiretroviral therapy (HAART) are a consequence of the restoration of pathogen-specific immune responses, a single-centre retrospective study of all HIV-infected patients commencing HAART prior to 1 July 1997 was undertaken to determine the incidence, characteristics and time of onset of disease…
A working group of the European AIDS Clinical Society (EACS) have developed these guidelines for European clinicians to help them in the treatment of adults with HIV infection. This third version of the guidelines includes, as new topics, the assessment of patients at initial and subsequent clinic visits as well as post-exposure prophylaxis. A revision…
